chr16-87888240-T-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001739.2(CA5A):c.807A>T(p.Ala269=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.195 in 1,613,382 control chromosomes in the GnomAD database, including 31,937 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2453 hom., cov: 32)
Exomes 𝑓: 0.20 ( 29484 hom. )
Consequence
CA5A
NM_001739.2 synonymous
NM_001739.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.78
Genes affected
CA5A (HGNC:1377): (carbonic anhydrase 5A) Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA VA is localized in the mitochondria and expressed primarily in the liver. It may play an important role in ureagenesis and gluconeogenesis. CA5A gene maps to chromosome 16q24.3 and an unprocessed pseudogene has been assigned to 16p12-p11.2. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 16-87888240-T-A is Benign according to our data. Variant chr16-87888240-T-A is described in ClinVar as [Benign]. Clinvar id is 379955.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-87888240-T-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.78 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.258 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CA5A | NM_001739.2 | c.807A>T | p.Ala269= | synonymous_variant | 7/7 | ENST00000649794.3 | NP_001730.1 | |
CA5A | NM_001367225.1 | c.774+3559A>T | intron_variant | NP_001354154.1 | ||||
CA5A | NR_159798.1 | n.994A>T | non_coding_transcript_exon_variant | 8/8 | ||||
CA5A | NR_159799.1 | n.767A>T | non_coding_transcript_exon_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CA5A | ENST00000649794.3 | c.807A>T | p.Ala269= | synonymous_variant | 7/7 | NM_001739.2 | ENSP00000498065 | P1 |
Frequencies
GnomAD3 genomes AF: 0.174 AC: 26391AN: 151892Hom.: 2449 Cov.: 32
GnomAD3 genomes
AF:
AC:
26391
AN:
151892
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.183 AC: 45841AN: 250754Hom.: 4598 AF XY: 0.190 AC XY: 25736AN XY: 135506
GnomAD3 exomes
AF:
AC:
45841
AN:
250754
Hom.:
AF XY:
AC XY:
25736
AN XY:
135506
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.198 AC: 288821AN: 1461372Hom.: 29484 Cov.: 32 AF XY: 0.201 AC XY: 145884AN XY: 726964
GnomAD4 exome
AF:
AC:
288821
AN:
1461372
Hom.:
Cov.:
32
AF XY:
AC XY:
145884
AN XY:
726964
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.174 AC: 26404AN: 152010Hom.: 2453 Cov.: 32 AF XY: 0.172 AC XY: 12803AN XY: 74292
GnomAD4 genome
AF:
AC:
26404
AN:
152010
Hom.:
Cov.:
32
AF XY:
AC XY:
12803
AN XY:
74292
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
708
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:2
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 23, 2016 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 24, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at